middle.news
AdAlta Secures EW-001 CAR-T Rights and Advances Manufacturing with FDA Engagement in Sight
9:23am on Wednesday 29th of July, 2026 AEST
•
Biotechnology
Read Story
AdAlta Secures EW-001 CAR-T Rights and Advances Manufacturing with FDA Engagement in Sight
9:23am on Wednesday 29th of July, 2026 AEST
Key Points
US$1 million milestone payment secures EW-001 development rights
Australian manufacturing transfer underway with first runs due H2 2026
Pre-IND meeting with US FDA anticipated in second half of 2026
A$2.5 million placement funds milestone and operational activities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE